BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38336791)

  • 1. Detection of gene mutation in the prognosis of a patient with arrhythmogenic right ventricular cardiomyopathy: a case report.
    Phan DP; Tran TV; Le VK; Nguyen TV
    J Med Case Rep; 2024 Feb; 18(1):49. PubMed ID: 38336791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
    Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
    Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
    Blusztein DI; Zentner D; Thompson T; Jayadeva P; Liang D; Wang R; Winship I; James PA; Trainer AH; Kalman JM; Vohra J
    Heart Lung Circ; 2019 Jul; 28(7):1034-1041. PubMed ID: 30126789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
    Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
    JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.
    Azaouagh A; Churzidse S; Konorza T; Erbel R
    Clin Res Cardiol; 2011 May; 100(5):383-94. PubMed ID: 21360243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Bosman LP; Te Riele ASJM
    Heart; 2022 Jan; 108(2):90-97. PubMed ID: 33990412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
    Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy.
    Zinkovsky D; Sood MR
    J Cardiovasc Electrophysiol; 2023 Oct; 34(10):2112-2121. PubMed ID: 37717241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
    Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Silvano M; Corrado D; Köbe J; Mönnig G; Basso C; Thiene G; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2013 Dec; 24(4):202-8. PubMed ID: 24113835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
    Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
    Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report of familial sudden cardiac death caused by a DSG2 p.F531C mutation as genetic background when carrying with heterozygous KCNE5 p.D92E/E93X mutation.
    Lin Y; Huang J; He S; Feng R; Zhong Z; Liu Y; Ye W; Li X; Liao H; Fei H; Rao F; Shan Z; Deng C; Zhan X; Xue Y; Liu H; Zhang B; Wang K; Zhang Q; Wu S; Lin X
    BMC Med Genet; 2018 Aug; 19(1):148. PubMed ID: 30129429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of arrhythmogenic right ventricular cardiomyopathy.
    Silvano M; Mastella G; Zorzi A; Migliore F; Pilichou K; Bauce B; Rigato I; Perazzolo Marra M; Iliceto S; Thiene G; Basso C; Corrado D
    Minerva Med; 2016 Aug; 107(4):194-216. PubMed ID: 27186923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.